首页|干细胞治疗淋巴水肿的基础及临床应用研究进展

干细胞治疗淋巴水肿的基础及临床应用研究进展

扫码查看
目的 综述不同类型干细胞及其联合疗法治疗淋巴水肿的基础和临床研究进展.方法 广泛查阅国内外近年干细胞治疗淋巴水肿有关文献,对不同类型干细胞治疗淋巴水肿的动物实验和临床研究进行总结.结果 动物实验和临床研究均显示各类干细胞治疗淋巴水肿有一定效果,主要通过局部分化为淋巴内皮细胞和旁分泌不同功能的细胞因子发挥作用.目前研究集中于脂肪来源干细胞和BMSCs两种细胞类型,两者各有优缺点,主要体现在干细胞治疗效果、获取难度和体内含量等方面.此外,干细胞还能联合其他治疗方式发挥协同作用,例如保守治疗、手术干预、细胞因子、生物支架等.但目前仍局限于基础研究阶段,仅少量研究完成了临床试验.结论 干细胞治疗淋巴水肿具有较大临床转化潜力,但目前在细胞类型选择、移植细胞量、移植时机等方面尚缺乏统一标准.
Research advances on stem cell-based treatments in animal studies and clinical trials of lymphedema
Objective To summarize the progress of the roles and mechanisms of various types of stem cell-based treatments and their combination therapies in both animal studies and clinical trials of lymphedema.Methods The literature on stem cell-based treatments for lymphedema in recent years at home and abroad was extensively reviewed,and the animal studies and clinical trials on different types of stem cells for lymphedema were summarized.Results Various types of stem cells have shown certain effects in animal studies and clinical trials on the treatment of lymphedema,mainly through local differentiation into lymphoid endothelial cells and paracrine cytokines with different functions.Current research focuses on two cell types,adipose derived stem cells and bone marrow mesenchymal stem cells,both of which have their own advantages and disadvantages,mainly reflected in the therapeutic effect of stem cells,the difficulty of obtaining stem cells and the content in vivo.In addition,stem cells can also play a synergistic role in combination with other treatments,such as conservative treatment,surgical intervention,cytokines,biological scaffolds,and so on.However,it is still limited to the basic research stage,and only a small number of studies have completed clinical trials.Conclusion Stem cells have great transformation potential in the treatment of lymphedema,but there is no unified standard in the selection of cell types,the amount of transplanted cells,and the timing of transplantation.

Stem cellslymphedemalymphatic regenerationtissue engineeringregenerative medicine

陈君哲、邓呈亮

展开 >

遵义医科大学附属医院烧伤整形外科(贵州遵义 563003)

组织损伤修复与再生医学省部共建协同创新中心(贵州遵义 563003)

干细胞 淋巴水肿 淋巴管再生 组织工程 再生医学

贵州省科技计划重点项目贵州省科技计划项目贵州省科技计划项目中国教育部协同创新中心项目遵义医科大学未来著名临床医生计划项目

ZK2021-011[2021]079[2020]1Y3312020-39rc220211202

2024

中国修复重建外科杂志
中国康复医学会,四川大学华西医院

中国修复重建外科杂志

CSTPCD北大核心
影响因子:1.239
ISSN:1002-1892
年,卷(期):2024.38(1)
  • 61